2 recruiting, 2 unknown, 1 completed, 1 not yet recruiting. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Recruiting 2, Unknown 2, Completed 1, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Experimental drug: new trials by email Literature Review of Experimental drug trials Research Report on Experimental drug
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SALI-10 Probiotic to Reduce Osteoradionecrosis and Dental Toxicity Following Radiation Therapy for Head and Neck Cancer Standard of Care (SOC), Experimental drug - Head and Neck Cancer | Phase 3 | Not yet recruiting | University Health Network, Toronto | 288 | 2026-11-01 | 2026-10-20 |
| Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward Amoxicillin, Amoxicillin/clavulanate - Community-acquired Pneumonia | Phase 3 | Recruiting | Nantes University Hospital | 326 | 2024-04-25 | 2026-04-08 |
| Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC Experimental drug, Control Rx - Metastatic Microsatellite-stable Colorectal Cancer | Phase 3 | Recruiting | Sun Yat-sen University | 176 | 2023-03-01 | 2023-03-14 |
| Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status Experimental drug - Colorectal Cancer, Liver Metastases | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 40 | 2022-10-01 | 2022-06-08 |
| To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain. orphenadrine, acetaminophen, caffeine and diclofenac sodium, Diclofenac Sodium 50 MG, Placebo (for experimental drug) - Postural Low Back Pain, Mechanical Low Back Pain | Phase 3 | Unknown | Ache Laboratorios Farmaceuticos S.A. | 110 | 2021-01-01 | 2020-09-03 |
| Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease DS-5565, Placebo - Fibromyalgia | Phase 3 | Completed | Daiichi Sankyo | 56 | 2015-06-26 | 2020-11-24 |
| Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections 0.2% ropivacaine, Saline - Colorectal Disorders, Observation of Neuromuscular Block | Phase 3 | Withdrawn | Stamford Hospital | 2012-05-01 | 2016-12-06 |
Colorectal Neoplasms (2) · Community-Acquired Pneumonia (1) · Fibromyalgia (1) · Head and Neck Neoplasms (1) · Low Back Pain (1) · Renal Insufficiency, Chronic (1)
Ache Laboratorios Farmaceuticos S.A. (1) · Daiichi Sankyo (1) · Nantes University Hospital (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Stamford Hospital (1) · Sun Yat-sen University (1) · University Health Network, Toronto (1)
China (2) · United States (2) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Hungary (1) · Poland (1) · Romania (1) · South Africa (1) · Spain (1)
Mauro C Junior, M.D. (1) · Morton A Scheinberg, M.D. (1) · Pedro Henrique I Pohl, M.D. (1)
2014 (1)